• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19

tetano

Editor, Senior Moderator
PLoS One


. 2021 Feb 17;16(2):e0247041.
doi: 10.1371/journal.pone.0247041. eCollection 2021.
16S rRNA gene sequencing of rectal swab in patients affected by COVID-19


Antonio Mazzarelli[SUP] 1 [/SUP], Maria Letizia Giancola[SUP] 1 [/SUP], Anna Farina[SUP] 1 [/SUP], Luisa Marchioni[SUP] 1 [/SUP], Martina Rueca[SUP] 1 [/SUP], Cesare Ernesto Maria Gruber[SUP] 1 [/SUP], Barbara Bartolini[SUP] 1 [/SUP], Tommaso Ascoli Bartoli[SUP] 1 [/SUP], Gaetano Maffongelli[SUP] 1 [/SUP], Maria Rosaria Capobianchi[SUP] 1 [/SUP], Giuseppe Ippolito[SUP] 1 [/SUP], Antonino Di Caro[SUP] 1 [/SUP], Emanuele Nicastri[SUP] 1 [/SUP], Valerio Pazienza[SUP] 2 [/SUP], INMI COVID-19 study group



Affiliations

Abstract

COronaVIrus Disease-2019 (COVID-19) is a pandemic respiratory infection caused by a new betacoronavirus, the Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). Few data are reported on the gut microbiota in COVID-19 patients. 16S rRNA gene sequencing was performed to reveal an altered composition of the gut microbiota in patients with COVID-19 pneumonia admitted in intensive care unit (ICU) (i-COVID19), or in infectious disease wards (w-COVID19) as compared to controls (CTRL). i-COVID19 patients showed a decrease of Chao1 index as compared to CTRL and w-COVID19 patients indicating that patients in ICU displayed a lower microbial richness while no change was observed as for Shannon Index. At the phylum level, an increase of Proteobacteria was detected in w-COVID19 patients as compared to CTRL. A decrease of Fusobacteria and Spirochetes has been found, with the latter decreased in i-COVID19 patients as compared to CTRL. Significant changes in gut microbial communities in patients with COVID-19 pneumonia with different disease severity compared to CTRL have been identified. Our preliminary data may provide valuable information and promising biomarkers for the diagnosis of the disease and, when validated in larger cohort, it could facilitate the stratification of patients based on the microbial signature.
 
Back
Top Bottom